Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Prognostic Online (PIPO) Tool: a New Aid to Improve Patient Selection for Early Phase Clinical Trials

NCT07593053 is registered in ClinicalTrials.gov with Vall d'Hebron Institute of Oncology as lead sponsor.

NCT NCT07593053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07593053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Prognostic Online (PIPO) Tool: a New Aid to Improve Patient Selection for Early Phase Clinical Trials
Lead sponsor
Vall d'Hebron Institute of Oncology
Phase
Observational
Overall status
Completed
Start date
February 2, 2023
Completion date
April 30, 2026
Enrollment
586 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oncology